全文获取类型
收费全文 | 52447篇 |
免费 | 7423篇 |
国内免费 | 1575篇 |
专业分类
耳鼻咽喉 | 117篇 |
儿科学 | 685篇 |
妇产科学 | 590篇 |
基础医学 | 5497篇 |
口腔科学 | 604篇 |
临床医学 | 4518篇 |
内科学 | 3513篇 |
皮肤病学 | 224篇 |
神经病学 | 1122篇 |
特种医学 | 2249篇 |
外国民族医学 | 77篇 |
外科学 | 8734篇 |
综合类 | 7210篇 |
现状与发展 | 8篇 |
一般理论 | 1篇 |
预防医学 | 3096篇 |
眼科学 | 452篇 |
药学 | 3234篇 |
28篇 | |
中国医学 | 1270篇 |
肿瘤学 | 18216篇 |
出版年
2024年 | 99篇 |
2023年 | 760篇 |
2022年 | 1204篇 |
2021年 | 2533篇 |
2020年 | 2319篇 |
2019年 | 2120篇 |
2018年 | 2028篇 |
2017年 | 1990篇 |
2016年 | 2116篇 |
2015年 | 2498篇 |
2014年 | 3399篇 |
2013年 | 3770篇 |
2012年 | 2968篇 |
2011年 | 3223篇 |
2010年 | 2510篇 |
2009年 | 2507篇 |
2008年 | 2544篇 |
2007年 | 2658篇 |
2006年 | 2621篇 |
2005年 | 2472篇 |
2004年 | 2070篇 |
2003年 | 1910篇 |
2002年 | 1605篇 |
2001年 | 1418篇 |
2000年 | 1178篇 |
1999年 | 1006篇 |
1998年 | 787篇 |
1997年 | 766篇 |
1996年 | 626篇 |
1995年 | 535篇 |
1994年 | 393篇 |
1993年 | 360篇 |
1992年 | 315篇 |
1991年 | 280篇 |
1990年 | 213篇 |
1989年 | 167篇 |
1988年 | 171篇 |
1987年 | 153篇 |
1986年 | 134篇 |
1985年 | 193篇 |
1984年 | 155篇 |
1983年 | 121篇 |
1982年 | 125篇 |
1981年 | 133篇 |
1980年 | 84篇 |
1979年 | 63篇 |
1978年 | 47篇 |
1977年 | 39篇 |
1976年 | 29篇 |
1973年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 437 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
3.
4.
5.
《Diagnostic Histopathology》2022,28(3):156-160
Breast core biopsies are a standard component of the triple approach that includes clinical examination, imaging and tissue sampling. Conventional cores, diagnostic vacuum assisted biopsy and vacuum assisted excisions are established methods for sampling and managing breast lesions. It is important to be aware of the potential pitfalls in the technical handling and interpretation of the limited core biopsy samples. Here, we present a clinically oriented, well illustrated overview of the common diagnostic pitfalls based on the author's diagnostic and second opinion practice, emphasize the value of clinicopathological correlation and provide histological tips and clues with useful immunohistochemistry to aid the reporting pathologists in their daily interpretation of breast core biopsies. 相似文献
6.
7.
8.
阿尔茨海默病是一种进行性且不可逆转的神经系统疾病,由于视网膜和中枢神经系统有相似的胚胎起源和生理特征,眼科检查可提供简单无创的诊断方法。光学相干断层扫描技术(OCT)能够精确地测量视网膜各个组织层面的厚度,以评估视网膜的退行性改变,光学相干断层扫描血管成像(OCTA)可以提供高分辨率三维成像,从而更直观地检测视网膜血管的变化,间接地反映脑神经元和血管的病理特征。就OCT测量视网膜厚度及OCTA测量视网膜血流变化在阿尔茨海默病诊断中的研究进展进行综述。 相似文献
9.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
10.